ADVERTISEMENT
Pharma Q4 Results Review — India Traction Healthy; Post gRevlimid Uncertainty Looms, Says ICICI Securities
Pharma Q4 Results Review: Sun Pharma, Cipla, Torrent, Piramal Pharma, Akums and Abbott India among ICICI Securities top picks
09 Jun 2025, 01:37 PM IST 
Among ICICI Securities' coverage universe, Dr Reddy’s grew the fastest at 15.8% YoY driven by inlicensed brands, Sun Pharma at 13.6% YoY and Ajanta Pharma at 13.2% YoY.
(Image by Myriams-Fotos from Pixabay)
The India business of the brokerage's coverage companies grew 10.2% YoY to Rs 207 billion in Q4 FY25 driven by better pricing, volumes and new launches. Among coverage universe, Dr Reddy’s grew the fastest at 15.8% YoY driven by inlicensed brands, Sun Pharma at 13.6% YoY and Ajanta Pharma at 13.2% YoY.
